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Antibodies were raised, in rabbits, against an arachidonate- and U46619-binding protein purified from calf 
platelets. Spectral measurements and immunodiffusion experiments were employed to follow conformation- 
al responses of the protein in relation to platelet activation. Upon treatment with the platelet agonists, 
arachidonate and PGH,, as well as the common haem ligands, imidazole and CN-, the purified protein 
had its Soret band red-shifted, with h~hromicity, but the protein saturated with the agonists, not with 
the haem ligands, showed altered antigenic properties in immunodiffusion experiments. In an analogous 
manner activation of gel-filtered calf platelets with high concentrations of ADP and A23 187, as well as by 
cold, had Soret bands of extracts of sonicated platelets red-shifted, with hypochromicity; concomitantly, 
antigenically different conformations of the protein appeared in Triton X-100 extracts of the activated plate- 
lets. A protein immunologically related to the platelet protein was detected in Triton X-100 extracts of calf 
neutrophils. It is suggested that confo~ational changes of the protein induced by arachidonate or 
prostaglandin endoperoxides or H,O, formed in different compartments during platelet activation by differ- 
ent stimuli may be a biochemical mechanism of stimulus-response coupling and that similar mechanisms 
might operate in other cell types. 
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1. INTRODUCTION 
Blood platelets can be activated to varying 
degrees and stages by numerous stimuli, depending 
on their nature, dose, and duration of action. 
Some stimuli such as physiological ADP and 
thrombin act through their respective, specific, 
cell-surface receptors [1,2]. In contrast, some other 
stimuli such as the synthetic calcium ionophore, 
A23187, or physical agents like prosthetic surfaces 
[3,4] or low temperatures ([5] and references 
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therein) activate independently of specific cell- 
surface receptors. 
The mechanisms of stimulus-response coupling 
in platelets are not well understood at present 
[6,7]. However, a funnel-like channelling of dif- 
ferent biochemical effects of diverse stimuli into a 
few response pathways appears to be discernible 
M%91. 
Nothing is known about he mechanisms of 
channeling bioche~cal signals towards response. 
Recently we reported the purification, from calf 
platelets, of a haemoprotein that could bind both 
arachidonate and the PGHz/thromboxane AZ 
(TxA2) analogue, U-46619 [lo]. The half- 
saturation con~ntration of U-46619 was in the 
range that induces platelet aggregation [I I, 121. 
This lent credence to the view [IO] that the protein 
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could be a prostaglandin endoperoxide receptor. 
Consistent with this view and reports by others 
[ 11,131 that U-46619 can function as a platelet 
agonist independently of a TxA2 receptor we have 
found that pinane-TxAz, a specific TxAz receptor 
antagonist [141, is devoid of significant binding in- 
teraction with the haemoprotein and fails to inhibit 
U-46619-induced activation of gel-filtered calf 
platelets (unpublished). To define further the role 
of the protein in platelet activation we have now 
raised antibodies against it in rabbits. The results 
of spectral measurements and immunodiffusion 
experiments, reported here, suggest that confor- 
mational changes of the protein might form a 
mechanism of channelling biochemical signals of 
activation of calf platelets by ADP, A23187, and 
low temperatures. 
2. MATERIALS AND METHODS 
2.1. Materials 
All unsaturated fatty acids, agar, Ficoll (type 
400), imidazole, sodium diatrizoate (Hypaque), 
Triton X-100, and Tris base were from Sigma 
(USA). Hz02 was a product of Glaxo Labora- 
tories, India. Its concentration in experimental 
systems was estimated spectrophotometrically 
using Ego 40 M-‘-cm-’ at pH 7.4. PGHz was 
prepared as in [15] but employing microsomes 
prepared from calf platelets. All other chemicals 
were of the highest purity available commercially. 
Deionized double quartz-distilled water was em- 
ployed. All buffer solutions were filtered through 
a Millipore filter (0.45 pm). All operations were 
carried out at 30 f 1°C (ambient temperature) 
unless otherwise stated. Collection, storage and 
centrifugation of blood and platelet preparations 
were in polypropylene tubes. Pipetting of platelet 
preparations was done using automatic pipettes 
and polypropylene tips. 
2.2. Preparation of gel-filtered platelets (GFP) 
Calf (male) blood collected by jugular venic 
puncture into l/10 vol. acid-citrate-dextrose solu- 
tion was centrifuged at 86 x g (rav 7.7 cm) for 
15 min. The platelet-rich plasma (PRP) was 
recovered and centrifuged again at 24 x g (ray 
8.5 cm) for 20 min to remove residual erythrocytes 
and leukocytes. GFP were obtained according to 
Tangen and Berman [16] using their noncolloidal 
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buffer, at pH 7.4. Only those preparations in 
which at least 90% appeared as single platelets, 
under the microscope, were used for studying the 
spectral and immunological effects upon ac- 
tivation. 
2.3. Purification of calf neutrophils 
The buffy coat obtained after removing PRP 
(section 2.2) was diluted 10 times with 0.13 M 
NaCl. Lymphocytes were removed from the 
suspension by the method of Boyum [17] and 
erythrocytes by the method of Boyle [18] except 
for the removal of debri of lysed red cells which 
was achieved by centrifugation at 3.8 x g (rav 
8.5 cm) for 10 min. The neutrophil preparations 
were washed 3 times with 0.12 M NaCl by cen- 
trifugation at 24 x g (r,, 8.5 cm) for 15 min. The 
purity of the final preparation was checked by ex- 
amining its smear stained with Lieshman’s stain 
under the microscope. 
2.4. Purification of protein 
The PRP obtained as in section 2.2 from 500 ml 
blood was centrifuged again at 345 x g (rav 7.7 cm) 
for 15 min and the platelet-poor plasma (PPP) and 
platelet button were recovered separately. Platelets 
were reconstituted with 30 ml PPP and gel-filtered 
as in section 2.2, loading 10 ml at a time. GFP 
were made up to 100 ml and broken ultrasonically 
at 2O”C, in 20 ml batches [IO]. Broken platelets 
were centrifuged at 54000 x g (rav 7.7 cm) for 
30 min at 4°C and the supernatants (crude ex- 
tracts) were processed as in [lo] up to Sephadex 
G-200 column chromatography. Fractions having 
A405 > 0.05 were then loaded onto a DEAE- 
Sephadex A-50 column, in the order in which they 
emerged from the Sephadex G-200 column, and 
eluted as in [lo], in a cold room (4°C). 
2.5. Immunological techniques 
Antibodies against the purified protein were 
raised in rabbits as in [19]. The purified haemopro- 
tein (150 pg) emulsified in Freund’s adjuvant was 
used for primary injection. Two booster injections 
of 100 pug protein each time were given on the 15th 
and 28th days. The antiserum collected on the 35th 
day was clarified by centrifugation at 54000 x g 
(r,, 7.7 cm) and stored at - 20°C in small aliquots. 
Ouchterlony immunodiffusion experiments were 
carried out in agar gels as described [20], and 
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Fig. 1. Results of Ouchterlony immunodiffusion 
experiments using rabbit antiserum (A) and normal 
rabbit serum (B). The antiserum (50~1, 1.2 rng protein) 
taken in the central well was allowed to react with 1.8 pg 
antigen in the peripheral wells. Other procedures were as 
given in the text. 
350 400 500 
wavelength, nm 
precipitin lines were allowed to develop in a cold 
room (4’C) for 48 h. The gels were stained and 
destained according to [20]. The stained precipitin 
lines were photographed. 
3. RESULTS 
The modified purification procedure yielded 
sufficient pure haemoprotein to raise antibodies 
against it, in rabbits. Immunodiffusion, in agar 
gels, showed the formation of a single precipitin 
line (fig.lA) when rabbit antiserum was tested 
against the purified protein, in contrast to the 
absence of any precipitin reaction with normal rab- 
bit serum (fig.lB). 
We reported [IO] a batch-to-batch variability of 
the Soret band maximum of crude extracts of the 
protein. We suspected this to be due to varying 
degrees of activation of the platelets in vivo, or 
during handling, and the consequent binding of 
low-M, ligands to the protein because binding of 
platelet-stimulatory ligands to the purified protein 
has been found to bring about such spectral effects 
[lo]. To test this possibility, GFP, of which the 
Soret band maximum of crude extracts had pre- 
viously been determined to occur at 405 nm, were 
Fig.2. (A) Spectral properties of crude extracts of gei- 
filtered calf platelets before and after activation. GFP 
(2 ml, 6 x IO8 platelets/ml) were activated with ADP 
(10pM) or A23187 (5 nM) for 10 min at 32°C. Crude 
extracts of the platelets were prepared as described in the 
text and their absorption spectra recorded at 2YC 
employing a Shimadzu UV-240 recording spectro- 
photometer using the gel-filtration column buffer as 
reference. The spectra shown are those of crude extracts 
of control platelets (l), ADP-activated piatelets (2), and 
A23187-activated platelets (3). (B) Typical irnrnunodif- 
fusion patterns of Triton X-100 extracts of activated caIf 
platelets. GFP (1 ml, 6 x 10’ platelets) were activated by 
lowering the temperature (1 h in melting ice), ADP and 
A23187 (as in A). The activated platelets were treated 
with Triton X-100 added to a final concentration of 1% 
(v/v) and mixed. The Triton X-100 extracts (30 ~1) were 
then taken in the periphery wells 2, 5 and 6, respec- 
tively. Similarly prepared Triton X-100 extracts of 
control platelets and platelets rewarmed at 32OC for 1 h 
after cold activation were taken in wells 1 and 2, 
respectively. The purified protein (2.2 lg) was taken in 
well 4. The antibody was present in the central well. 
Other details were as described in the text. 
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activated with ADP (10 ,uM) and A23 187 (5 nM), 
as being representative of stimuli acting through 
cell-surface receptor-dependent and -independent 
mechanisms. These agents by themselves did not 
affect the Soret band of the purified protein. The 
Soret bands of crude extracts of the activated 
platelets were found to be red-shifted with hypo- 
*O.Os m r0.03 ~11’0.02 
-003 II -0.03 I-O.02 
350 450 350 450 
wovelength, nm wavelength, nm 
Fig.3. Difference spectral patterns obtained on 
saturating the calf platelet haemoprotein with various 
ligands. The purified protein sample (1 ml, 45 pg 
protein, A4e5 = 0.088) was taken in each of a pair of 
matched spectrophotometric cuvettes (path length 
10 mm) and placed in the sample and reference positions 
of a Shimadzu UV-240 recording spectrophotometer 
provided with a thermostatted cuvette holder, 
maintained at 25OC. The baseline was corrected 
automatically. Increasing concentrations of each ligand 
(1~1 volume increments) were added to the sample 
cuvette and an equal volume of the diluent to the 
reference cuvette. Difference spectra were recorded 
2 min after each addition and mixing, until no further 
spectral change was detected. The spectra shown in A 
are those obtained with 33.8 pM 5,8,11-eicosatrienoic 
acid (l), 39pM arachidonic acid (2), added as their 
ethanolic solutions, and 25 M NaCN (aqueous solution 
adjusted to pH 7.4 with dilute HCl) (3). Spectra in B are 
those obtained with 6 pl of an acetone solution of PGHz 
(-5 PM) (l), 8.5 mM imidazole (aqueous solution, 
adjusted to pH 7.4) (2), and 56/M Hz02 (3). 
chromicity compared to those of the control 
platelets (fig.2A). Similar but milder red shifts oc- 
curred with platelets activated by cooling at 0-4°C 
for 1 h (not shown). 
Immunodiffusion experiments showed two 
precipitin lines when Triton X-100 extracts of the 
activated platelets were used whereas only one line 
could be detected in extracts of control platelets 
(fig.2B). The double precipitin lines did not disap- 
pear on warming the cold-activated platelets, for 
1 h, at ambient temperature (figs 2B,3). 
Spectral and immunological methods were also 
employed to test whether similar conformational 
changes could be induced by ligand binding to the 
purified protein. 
The saturation of the protein by different 
ligands was followed by difference spectral 
methods [lo] and the protein treated with a 
saturating concentration of each ligand (fig.3) was 
taken in peripheral wells, alternated with the 
purified protein, in immunodiffusion experiments. 
The results (fig.4A) showed that when arachido- 
nate, or 5,8,11-eicosatrienoic acid, or Hz02 was 
bound only faint precipitin lines were formed 
which contrasted with those formed with the 
authentic protein in shape and position. In the case 
of PGH2 only a slight shift in position of the 
precipitin line towards the peripheral well occurred 
(figs 2,4B). The protein was, apparently, not 
saturated with PGHz as may be judged from fig.3B 
because of limitations of the volume of the solvent 
Fig.4. Immunodiffusion patterns obtained using protein 
saturated with various ligands as antigen. The protein 
samples (30 ~1) from the sample cuvettes of experiments 
in fig.3 were taken in peripheral wells alternated with the 
same volume of the contents of their respective reference 
cuvettes. Wells 2, 4 and 6 contained protein saturated 
with HzOz, arachidonic acid and 5,8,11-eicosatrienoic 
acid, respectively in A, and PGHz, imidazole and CN-, 
respectively, in B. Other details were as given in the text. 
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Fig.% Immunological detection of a protein 
antigenically related to the platelet protein, in calf 
neutrophils. (A) Purified calf platelet protein (2 pg) (1) 
and Triton X-100 extract (30.~41) of calf neutrophils (2) 
prepared as in the text. (B) Triton X-100 extract of caK 
plateiets prepared as described in the text (1) and Triton 
X-100 extract of calf neutrophils (2). 
(acetone) that could be added to the protein and in- 
stability of the compound. 
The precipitin lines formed in the presence of 
saturating concentrations of CN- and imidazole 
seemed indistinguishable from those of the authen- 
tic protein (fig.4B). 
Arachidonate can activate platelets without hav- 
ing recourse to metabolic conversion to pros- 
taglandin endoperoxides and thromboxane AZ 
([21]; unpublished). Arachidonate and other fatty 
acids also activate neutrophils [22]. These observa- 
tions prompted us to examine whether calf 
neutrophils possessed a similar protein and the 
results (fig.5) showed the presence of an an- 
tigenically related protein in Triton X-100 extracts 
of calf neutrophils. 
4. DISCUSSION 
Pooling of protein fractions eluted from the 
Sephadex G-200 column, ~H4)2so4 precipitation 
and the subsequent dialysis employed in the 
previous method [lo] resulted in haem loss and 
conformational heterogeneity of the protein mak- 
ing it unsuitable for raising antibodies. This was 
rectified in the present method of loading the peak 
fractions of the Sephadex G-200 column to the 
DEAE-Sephadex A-50 column, in the order in 
which they emerged, without mixing. This brought 
forth peak fractions from the DEAE-Sephadex 
column each of which was more concentrated 
haemoprotein than the whole protein recovered in 
the original method. 
Crude extracts of platelets that had not been ac- 
tivated had their Soret band centred on 405 nm 
(fig.lZA) as had the purified protein [lo]. The 
binding of low-M, physiological agonists like 
arachidonate, PGHz and Hz02 as well as common 
haem ligands such as imidazole or CN- induced a 
red shift of the Soret band of the purified protein 
with hypochromicity. However, binding of the 
former group of compounds alone could change 
the conformation of the protein to form precipitin 
lines closer to the antigen wells in immunodiffu- 
sion experiments (fig.4). The location of the 
precipitin lines indicated an increase in the ap- 
parent MI of the antigen. ~ac~donate is known 
to oligomerize the protein [lo]. The other agonists 
might also do so. 
Hz02 is a platelet agonist which seems to play a 
role in the aggregation of platelets by certain other 
agonists [23], probably by acting as an endoperox- 
ide analogue. 
When gel-filtered platelets were activated by 
ADP, A23187 or by chilling the Soret bands of 
their crude extracts were red-shifted with 
hypochromicity relative to those of the control 
platelets, mimicking the effect of binding of low- 
M, ligands to the protein. Furthermore, Triton 
X-100 extracts of activated platelets showed the 
appearance of two precipitin lines, one of which 
was closer to the antigen wells, as in the case of 
lig~d-treated protein. 
But intensity differences were apparent between 
precipitin lines of activated platelets (fig.2B) and 
ligand-saturated protein (fig.4A). A plausible ex- 
planation for this was discerned from the dif- 
ference spectra of saturation of the protein by 
increasing concentrations of the ligands. These 
spectra generally lacked isosbestic points (not 
shown) indicating formation of more than one 
type of complex. The immunological properties of 
variously saturated protein might then differ as ex- 
emplified by the precipitin line formed in the case 
of PGHz (fig.2,4B) and might form the basis for 
the intensity differences of precipitin lines. 
An explanation for the presence of two 
precipitin lines after platelet activation (fig.2B) 
could be that agonist ligands are liberated or 
formed in response to specific stimuli at specific 
platelet compartments and the protein at the site of 
agonist availability only might respond. 
The implied role of this protein in cold-induced 
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activation of platelets is intriguing. Enzymatic 
reactions undoubtedly occur during cold activation 
as evidenced by the phosphorylation of myosin 
light chain [5,24], a 47 kDa protein, and a 36 kDa 
protein of unknown function [5]. Arachidonate 
liberation could also occur since phospholipase AZ 
might act at low temperatures (e.g. 1253). But 
metabolic conversion of arachidonate did not oc- 
cur as we could not detect any significant dif- 
ference in malondialdehyde formation by the 
thiobarbituric acid reaction [26,27] between cold- 
activated and control platelets (unpublished). 
Three possible explanations can be offered to ac- 
count for these results: (if cooling strengthened the 
interaction of the prostaglandin endoperoxides 
with the protein without a change in their levels; 
(ii) covalent modification is known to increase the 
sensitivity of biological response reactions [28,29] 
and the endoperoxides, at the same level, might 
have triggered protein conformational change in 
platelets which have undergone cold-induced pro- 
tein phosphorylation (assuming priority of protein 
phosphorylation); and (iii) arachidonate which 
might be released uring cold activation could bind 
directly to the protein triggering the activation 
cascade. 
The third possibility is more interesting for the 
following reasons. Arachidonate does indeed ac- 
tivate platelets without having recourse to 
metabolic conversion (1211; and unpublished). In- 
itial rate kinetics of arachidonate-induced aggrega- 
tion of gel-filtered calf platelets exhibited apparent 
positive cooperativity with h = 3.8 f 0.3 (mean + 
SE, n = 9; unpublished). The binding of 
arachidonate to the purified protein also showed 
apparent positive cooperativity [IO] and its half- 
saturation concentration was in the range required 
to induce aggregation of gel-filtered platelets (un- 
published). Furthermore, arachidonate binding to 
the protein is accompanied by its irreversible 
modification ([lo]; and unpublished) and the im- 
munologically detected conformational change 
following cold activation was not reversed by 
rewarming the activated platelets (figs 2B,3). It 
may be noted, in this connection, that Pribluda 
and Rotman [9] found that cycles of temperature- 
mediated activation-deactivation of actin polymer- 
ization in platelets became refractory after a few 
cycles. 
Direct activation of platelets by unsaturated fat- 
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ty acids has previously been reported and inter- 
preted in terms of membrane fluidity changes [30]. 
In neutrophils arachidonate and other unsaturated 
fatty acids may function directly by an effect on 
protein kinase C [22]. It is intriguing that a protein 
immunologic~ly similar to the platelet haemopro- 
tein has been detected in calf neutrophils. 
In summary we have found a parallelism be- 
tween the behaviour of the purified calf platelet 
haemoprotein towards platelet-agonist ligands and 
the behaviour of the same protein during platelet 
activation, by spectral measurements and im- 
munodiffusion experiments. Although the possi- 
bility that some other ligands or effects or both 
might operate to change the conformation of the 
protein in vivo has not been ruled out, it is tempt- 
ing to speculate that conformational changes in- 
duced by arachidonate, PGGz/PGHz or possibly 
Hz02 formed in apparently different compart- 
ments of platelets during activation by various 
stimuli may form a biochemical mechanism of 
stimulus-response coupling in platelets and that 
similar mechanisms might operate in other cell 
types. 
ACKNOWLEDGEMENT 
This work was supported in part by a grant from 
the Department of Science and Technology, 
Government of India. 
REFERENCES 
Ul 
121 
t31 
[41 
PI 
161 
171 
Berndt, M.C. and Phillips, D.R. (1981) in: PlateIets 
in Biology and Pathology-2 (Gordon, J.L. ed.) 
pp.43-7.5, EIsevier/North-Holland, Amsterdam, 
New York. 
Colman, R.W. (1984) Mol. Cell. Biochem. 59, 
101-111. 
Mason, R.G., Mohammed, S.F., Chuang, H.Y.K. 
and Richardson, P.E. (1976) Semin. Thromb. 
Haemostas. 3, 98-116. 
White, J.G., Krumweide, M. and John, J. (1985) 
Blood 65, 1494-1503. 
Nachmias, V.T., Kavaler, J. and Jacubowitz, S. 
(1985) Nature 313, 70-72. 
Rink, T.J. and Haham, T.J. (1984) Trends 
Biochem. Sci. 9, 215-219. 
Majerus, P.W., Wilson, D.B., Connolly, T.M., 
Bross, T.E. and Neufeld, E.J. (1985) Trends 
Biochem. Sci. 10, 168-171. 
Volume 212, number 2 FEBS LETTERS February 1987 
[8] Nachmias, V.T. (1983) Semin. Haematol. 20, [20] Ouchterlony, 0. (1949) Acta Pathol. Microbial. 
261-281. Stand. 26, 507. 
[9] Pribluda, V. and Rotman, A. (1982) Biochemistry 
21, 2825-2832. 
[lo] Jamaluddin, M. and Krishnan, L.K. (1985) FEBS 
Lett. 183, 287-292. 
[l l] Di Minno, G., Bertele, V., Bianchi, L., Barbieri, 
B., Cerletti, C., Dejana, E., De Gaetano, G. and 
Silver, M.J. (1981) Thromb. Haemostas. 45, 
103-106. 
[12] Siess, W., Boehlig, B., Weber, P.C. and Lepetina, 
E.G. (1985) Blood 65, 1141-1148. 
[13] Bonne, C., Martin, B. and Regnault, F. (1980) 
Thromb. Res. 20, 701-704. 
[21] Yashiaki, H., Chikayuki, N. and Shoji, K. (1985) 
Biochim. Biophys. Acta 841, 283-291. 
[22] Mephail, L.C., Clayton, C.C. and Synderman, R. 
(1984) Science 224, 622-624. 
[23] Del Principle, D., Menichelli, A., DeMatteis, W., 
Di Corpo, M.L., Di Giulis, S. and Finazzi-Agro, 
A. (1985) FEBS Lett. 185, 142-146. 
[24] Bennet, W.F. and Lynch, G. (1980) J. Cell Biol. 86, 
280-285. 
[14] Nicolaou, K.C., Magolda, R.L., Smith, J.B., 
Aharony, D., Smith, E.F. and Lefer, A.M. (1979) 
Proc. Natl. Acad. Sci. USA 76, 2566-2570. 
[15] Graff, G. (1982) Methods Enzymol. 86, 376-386. 
[16] Tangen, 0. and Berman, H.J. (1972) in: Platelet 
Function and Thrombosis (Mannucci, P.M. and 
Gorini, S. eds) pp.235-243, Plenum, New York. 
[17] Boyum, A. (1968) Stand. J. Clin. Lab. Invest. 21, 
supp1.97, p. 1. 
[25] Pepinsky, R.B., Sinclair, L.K., Browning, J.L., 
Mettaliano, R.J., Smart, J.E., Chow, E.P., Falbel, 
T., Ribolini, A., Garwin, J.L. and Wallner, B.P. 
(1986) J. Biol. Chem. 261, 4239-4246. 
[26] Stuart, M.J., Murphy, S. and Oski, F.A. (1975) N. 
Engl. J. Med. 292, 1310-1313. 
[27] Best, L.C., Jones, P.B.B. and Russel, R.G.G. 
(1980) Clin. Sci. 59, 131-135. 
[28] Goldbeter, A. and Koshland, D.E. jr (1984) J. Biol. 
Chem. 259, 1441-1447. 
[18] Boyle, W. (1968) Transplantation 6, 761. 
[19] Jurd, R.D. (1981) in: Gel Electrophoresis of 
Proteins: A Practical Approach (Homes, B.D. and 
Rickwood, D. eds) pp.230-231, IRL, Oxford. 
[29] Schacter, E., Chock, P.B. and Stadtman, E.R. 
(1984) J. Biol. Chem. 259, 12252-12259. 
[30] Kitagawa, S., Endo, J. and Kametani, F. (1984) 
Biochim. Biophys. Acta 802, 17-23. 
219 
